Page contents Key factsDecisionRelated medicine informationKey facts Invented name OngentysOntilyv Active Substance opicapone Therapeutic area Neurology Decision number P/0260/2023 PIP number EMEA-003406-PIP01-23 Pharmaceutical form(s) Capsule, hard Condition(s) / indication(s) Treatment of Parkinson's disease Route(s) of administration Oral use Contact for public enquiries BIAL - Portela & Ca, SAE-mail: info@bial.comTel. +351 229866100 Decision type W: decision granting a waiver in all age groups for all conditions or indications Decision date 14/07/2023DecisionP/0260/2023 : EMA decision of 14 July 2023 on the granting of a product specific waiver for opicapone (Ongentys, Ontilyv), (EMEA-003406-PIP01- 23)Reference Number: EMA/284059/2023 English (EN) (207.18 KB - PDF)First published: 16/07/2024ViewRelated medicine informationOngentysOntilyvShare this page